Ian S. Hagemann, Ph.D. - Publications

2008 Washington University, Saint Louis, St. Louis, MO 
Cell Biology, Molecular Biology

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Hagemann IS, O'Neill PK, Erill I, Pfeifer JD. Diagnostic yield of targeted next generation sequencing in various cancer types: An information-theoretic approach. Cancer Genetics. PMID 26227479 DOI: 10.1016/j.cancergen.2015.05.030  1
2015 Skala SL, Hagemann IS. Optimal sampling of grossly normal omentum in staging of gynecologic malignancies. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 34: 281-7. PMID 25760907 DOI: 10.1097/PGP.0000000000000148  1
2015 Zsiros E, Duttagupta P, Dangaj D, Li H, Frank R, Garrabrant T, Hagemann IS, Levine BL, June CH, Zhang L, Wang E, Marincola FM, Bedognetti D, Powell DJ, Tanyi J, et al. The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2840-50. PMID 25712684 DOI: 10.1158/1078-0432.CCR-14-2777  1
2015 Hagemann IS, Devarakonda S, Lockwood CM, Spencer DH, Guebert K, Bredemeyer AJ, Al-Kateb H, Nguyen TT, Duncavage EJ, Cottrell CE, Kulkarni S, Nagarajan R, Seibert K, Baggstrom M, Waqar SN, et al. Clinical next-generation sequencing in patients with non-small cell lung cancer. Cancer. 121: 631-9. PMID 25345567 DOI: 10.1002/cncr.29089  1
2014 Zhang B, Xing X, Li J, Lowdon RF, Zhou Y, Lin N, Zhang B, Sundaram V, Chiappinelli KB, Hagemann IS, Mutch DG, Goodfellow PJ, Wang T. Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers. Bmc Genomics. 15: 868. PMID 25286960 DOI: 10.1186/1471-2164-15-868  1
2014 Motz GT, Santoro SP, Wang LP, Garrabrant T, Lastra RR, Hagemann IS, Lal P, Feldman MD, Benencia F, Coukos G. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors. Nature Medicine. 20: 607-15. PMID 24793239 DOI: 10.1038/nm.3541  1
2014 Sehn JK, Hagemann IS, Pfeifer JD, Cottrell CE, Lockwood CM. Diagnostic utility of targeted next-generation sequencing in problematic cases. The American Journal of Surgical Pathology. 38: 534-41. PMID 24451277 DOI: 10.1097/PAS.0000000000000161  1
2014 Hagemann IS, Govindan R, Javidan-Nejad C, Pfeifer JD, Cottrell CE. Stabilization of disease after targeted therapy in a thymic carcinoma with KIT mutation detected by clinical next-generation sequencing. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: e12-6. PMID 24419427 DOI: 10.1097/JTO.0b013e3182a7d22e  1
2014 Cottrell CE, Al-Kateb H, Bredemeyer AJ, Duncavage EJ, Spencer DH, Abel HJ, Lockwood CM, Hagemann IS, O'Guin SM, Burcea LC, Sawyer CS, Oschwald DM, Stratman JL, Sher DA, Johnson MR, et al. Validation of a next-generation sequencing assay for clinical molecular oncology. The Journal of Molecular Diagnostics : Jmd. 16: 89-105. PMID 24211365 DOI: 10.1016/j.jmoldx.2013.10.002  1
2014 Hagemann IS. Overview of Technical Aspects and Chemistries of Next-Generation Sequencing Clinical Genomics. 3-19. DOI: 10.1016/B978-0-12-404748-8.00001-0  1
2013 Hagemann IS, Cottrell CE, Lockwood CM. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy. Cancer Genetics. 206: 420-31. PMID 24388712 DOI: 10.1016/j.cancergen.2013.11.003  1
2013 Hagemann IS, Pfeifer JD, Cao D. Mammaglobin expression in gynecologic adenocarcinomas. Human Pathology. 44: 628-35. PMID 23084633 DOI: 10.1016/j.humpath.2012.07.013  1
2013 Zaino RJ, Abendroth C, Yemelyanova A, Oliva E, Lim D, Soslow R, Delair D, Hagemann IS, Montone K, Zhu J. Endocervical involvement in endometrial adenocarcinoma is not prognostically significant and the pathologic assessment of the pattern of involvement is not reproducible. Gynecologic Oncology. 128: 83-7. PMID 23063759 DOI: 10.1016/j.ygyno.2012.09.035  1
2012 Lanitis E, Dangaj D, Hagemann IS, Song DG, Best A, Sandaltzopoulos R, Coukos G, Powell DJ. Primary human ovarian epithelial cancer cells broadly express HER2 at immunologically-detectable levels. Plos One. 7: e49829. PMID 23189165 DOI: 10.1371/journal.pone.0049829  1
2012 Hagemann IS, Pasha TL, Roberts SA, Yum SW, Zhang PJ. Aberrant connexin 43 and 26 expression in cervical dysplasia. Analytical and Quantitative Cytology and Histology / the International Academy of Cytology [and] American Society of Cytology. 34: 28-40. PMID 22590817  1
2012 Lanitis E, Poussin M, Hagemann IS, Coukos G, Sandaltzopoulos R, Scholler N, Powell DJ. Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 633-43. PMID 22127019 DOI: 10.1038/mt.2011.256  1
2012 Hwang WT, Adams SF, Tahirovic E, Hagemann IS, Coukos G. Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. Gynecologic Oncology. 124: 192-8. PMID 22040834 DOI: 10.1016/j.ygyno.2011.09.039  1
2011 Hagemann IS, Hagemann AR, LiVolsi VA, Montone KT, Chu CS. Risk of occult malignancy in morcellated hysterectomy: a case series. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 30: 476-83. PMID 21804400 DOI: 10.1097/PGP.0b013e3182107ecf  1
2011 Hagemann AR, Hagemann IS, Cadungog M, Hwang WT, Patel P, Lal P, Hammond R, Gimotty PA, Chu CS, Rubin SC, Birrer MJ, Powell DJ, Feldman MD, Coukos G. Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma. Cancer Biology & Therapy. 12: 367-77. PMID 21785280 DOI: 10.4161/cbt.12.4.16908  1
2011 Hagemann AR, Cadungog M, Hagemann IS, Hammond R, Adams SF, Chu CS, Rubin SC, Zhang L, Addya K, Birrer MJ, Gimotty PA, Coukos G. Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironment. Cancer Biology & Therapy. 12: 357-66. PMID 21785264 DOI: 10.4161/cbt.12.4.16951  1
2011 Facciabene A, Peng X, Hagemann IS, Balint K, Barchetti A, Wang LP, Gimotty PA, Gilks CB, Lal P, Zhang L, Coukos G. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature. 475: 226-30. PMID 21753853 DOI: 10.1038/nature10169  1
2009 Hagemann IS, Lewis JS. A retrospective comparison of 2 methods of intraoperative margin evaluation during partial nephrectomy. The Journal of Urology. 181: 500-5. PMID 19084870 DOI: 10.1016/j.juro.2008.10.020  1
2008 Finger S, Hagemann IS. Benjamin Franklin's risk factors for gout and stones: from genes and diet to possible lead poisoning. Proceedings of the American Philosophical Society. 152: 189-206. PMID 19244863  1
2008 Hagemann IS, Lu J, Lewis JS. Basaloid squamous cell carcinoma arising of the renal pelvis International Journal of Surgical Pathology. 16: 199-201. PMID 18417681 DOI: 10.1177/1066896907306197  1
2008 Hagemann IS, Miller DL, Klco JM, Nikiforovich GV, Baranski TJ. Structure of the complement factor 5a receptor-ligand complex studied by disulfide trapping and molecular modeling. The Journal of Biological Chemistry. 283: 7763-75. PMID 18195008 DOI: 10.1074/jbc.M709467200  1
2008 Hagemann IS, Lu J, Lewis JS. Basaloid squamous cell carcinoma arising in the renal pelvis (International Journal of Surgical Pathology (2008) 16, (199-201) DOI: 10.1177/ 1066896907306197) International Journal of Surgical Pathology. 16: 355. DOI: 10.1177/1066896908321993  1
2007 Hagemann IS, Narzinski KD, Baranski TJ. E2F8 is a nonreceptor activator of heterotrimeric G proteins. Journal of Molecular Signaling. 2: 3. PMID 17394670 DOI: 10.1186/1750-2187-2-3  1
2006 Hagemann IS, Narzinski KD, Floyd DH, Baranski TJ. Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking. The Journal of Biological Chemistry. 281: 36783-92. PMID 17023413 DOI: 10.1074/jbc.M607686200  1
2006 Hagemann IS, Nikiforovich GV, Baranski TJ. Comparison of the retinitis pigmentosa mutations in rhodopsin with a functional map of the C5a receptor. Vision Research. 46: 4519-31. PMID 16962629 DOI: 10.1016/j.visres.2006.07.010  1
2006 Foo ML, Huang Q, Lynn JW, Lee WL, Klimczuk T, Hagemann IS, Ong NP, Cava RJ. Synthesis, structure and physical properties of Ru ferrites: BaMRu 5O11 (M=Li and Cu) and BaM′2Ru 4O11 (M′=Mn, Fe and Co) Journal of Solid State Chemistry. 179: 563-572. DOI: 10.1016/j.jssc.2005.11.014  1
2001 Hagemann IS, Huang Q, Gao XP, Ramirez AP, Cava RJ. Geometric magnetic frustration in Ba(2)Sn(2)Ga(3)ZnCr(7)O(22): a two-dimensional spinel based Kagomé lattice. Physical Review Letters. 86: 894-7. PMID 11177967 DOI: 10.1103/PhysRevLett.86.894  1
2000 Hagemann IS, Khalifah PG, Ramirez AP, Cava RJ. Geometric magnetic frustration in olivines Physical Review B - Condensed Matter and Materials Physics. 62: R771-R774.  1
Show low-probability matches.